{
 "drug": "Quinapril/Hydrochlorothiazide Tablet",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "01/19/2023",
 "dayN": 1314,
 "cat": "Cardiovascular",
 "companies": [
  "Pfizer Inc.",
  "Chartwell Molecular Holdings LLC",
  "Aurobindo Pharma USA"
 ],
 "reasons": [
  "Discontinuation of the manufacture of the drug"
 ],
 "records": [
  {
   "update_type": "Reverified",
   "initial_posting_date": "01/19/2023",
   "package_ndc": "0071-0222-23",
   "generic_name": "Quinapril/Hydrochlorothiazide Tablet",
   "contact_info": "800-533-4535",
   "availability": "Unavailable",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Tablet",
   "presentation": "Accuretic, Tablet, 10 mg/12.5 mg (NDC 0071-0222-23)",
   "company_name": "Pfizer Inc.",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "01/19/2023",
   "package_ndc": "62135-667-90",
   "generic_name": "Quinapril/Hydrochlorothiazide Tablet",
   "contact_info": "845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA076374"
    ],
    "brand_name": [
     "QUINAPRIL AND HYDROCHLOROTHIAZIDE"
    ],
    "generic_name": [
     "QUINAPRIL AND HYDROCHLOROTHIAZIDE"
    ],
    "manufacturer_name": [
     "Chartwell RX, LLC"
    ],
    "product_ndc": [
     "62135-667",
     "62135-668",
     "62135-669"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "QUINAPRIL HYDROCHLORIDE",
     "HYDROCHLOROTHIAZIDE"
    ],
    "rxcui": [
     "310796",
     "310797",
     "310809"
    ],
    "spl_id": [
     "0c3f4504-d57e-aa79-e063-6294a90ad5b8"
    ],
    "spl_set_id": [
     "2eae533f-d0af-47e8-a1f2-94bc8cc89b5a"
    ],
    "package_ndc": [
     "62135-667-90",
     "62135-668-90",
     "62135-669-90"
    ],
    "nui": [
     "N0000175359",
     "N0000175419",
     "M0471776"
    ],
    "pharm_class_pe": [
     "Increased Diuresis [PE]"
    ],
    "pharm_class_epc": [
     "Thiazide Diuretic [EPC]"
    ],
    "pharm_class_cs": [
     "Thiazides [CS]"
    ],
    "unii": [
     "0J48LPH2TH",
     "33067B3N2M"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Tablet",
   "presentation": "Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 62135-667-90)",
   "company_name": "Chartwell Molecular Holdings LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "01/19/2023",
   "package_ndc": "65862-162-90",
   "generic_name": "Quinapril/Hydrochlorothiazide Tablet",
   "contact_info": "866-850-2876",
   "availability": "Unavailable",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA078450"
    ],
    "brand_name": [
     "QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE"
    ],
    "generic_name": [
     "QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE"
    ],
    "manufacturer_name": [
     "Aurobindo Pharma Limited"
    ],
    "product_ndc": [
     "65862-162",
     "65862-161",
     "65862-163"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "QUINAPRIL HYDROCHLORIDE",
     "HYDROCHLOROTHIAZIDE"
    ],
    "rxcui": [
     "310796",
     "310797",
     "310809"
    ],
    "spl_id": [
     "5842ecc2-874a-481b-8997-afa9d862dc5d"
    ],
    "spl_set_id": [
     "50a58159-9572-4445-9859-b392632597da"
    ],
    "package_ndc": [
     "65862-161-90",
     "65862-162-30",
     "65862-162-90",
     "65862-163-90"
    ],
    "nui": [
     "N0000175359",
     "N0000175419",
     "M0471776"
    ],
    "pharm_class_pe": [
     "Increased Diuresis [PE]"
    ],
    "pharm_class_epc": [
     "Thiazide Diuretic [EPC]"
    ],
    "pharm_class_cs": [
     "Thiazides [CS]"
    ],
    "unii": [
     "0J48LPH2TH",
     "33067B3N2M"
    ]
   },
   "update_date": "06/02/2026",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Tablet",
   "presentation": "Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 65862-162-90)",
   "company_name": "Aurobindo Pharma USA",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "01/19/2023",
   "package_ndc": "0071-0223-23",
   "generic_name": "Quinapril/Hydrochlorothiazide Tablet",
   "contact_info": "800-533-4535",
   "availability": "Unavailable",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Tablet",
   "presentation": "Accuretic, Tablet, 25 mg/20 mg (NDC 0071-0223-23)",
   "company_name": "Pfizer Inc.",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "01/19/2023",
   "package_ndc": "0071-0220-23",
   "generic_name": "Quinapril/Hydrochlorothiazide Tablet",
   "contact_info": "800-533-4535",
   "availability": "Unavailable",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Tablet",
   "presentation": "Accuretic, Tablet, 20 mg/12.5 mg (NDC 0071-0220-23)",
   "company_name": "Pfizer Inc.",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "01/19/2023",
   "package_ndc": "65862-163-90",
   "generic_name": "Quinapril/Hydrochlorothiazide Tablet",
   "contact_info": "866-850-2876",
   "availability": "Unavailable",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA078450"
    ],
    "brand_name": [
     "QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE"
    ],
    "generic_name": [
     "QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE"
    ],
    "manufacturer_name": [
     "Aurobindo Pharma Limited"
    ],
    "product_ndc": [
     "65862-163",
     "65862-161",
     "65862-162"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "QUINAPRIL HYDROCHLORIDE",
     "HYDROCHLOROTHIAZIDE"
    ],
    "rxcui": [
     "310796",
     "310797",
     "310809"
    ],
    "spl_id": [
     "5842ecc2-874a-481b-8997-afa9d862dc5d"
    ],
    "spl_set_id": [
     "50a58159-9572-4445-9859-b392632597da"
    ],
    "package_ndc": [
     "65862-161-90",
     "65862-162-30",
     "65862-162-90",
     "65862-163-90"
    ],
    "nui": [
     "N0000175359",
     "N0000175419",
     "M0471776"
    ],
    "pharm_class_pe": [
     "Increased Diuresis [PE]"
    ],
    "pharm_class_epc": [
     "Thiazide Diuretic [EPC]"
    ],
    "pharm_class_cs": [
     "Thiazides [CS]"
    ],
    "unii": [
     "0J48LPH2TH",
     "33067B3N2M"
    ]
   },
   "update_date": "06/02/2026",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Tablet",
   "presentation": "Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 65862-163-90)",
   "company_name": "Aurobindo Pharma USA",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "01/19/2023",
   "package_ndc": "65862-161-90",
   "generic_name": "Quinapril/Hydrochlorothiazide Tablet",
   "contact_info": "866-850-2876",
   "availability": "Unavailable",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA078450"
    ],
    "brand_name": [
     "QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE"
    ],
    "generic_name": [
     "QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE"
    ],
    "manufacturer_name": [
     "Aurobindo Pharma Limited"
    ],
    "product_ndc": [
     "65862-161",
     "65862-162",
     "65862-163"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "QUINAPRIL HYDROCHLORIDE",
     "HYDROCHLOROTHIAZIDE"
    ],
    "rxcui": [
     "310796",
     "310797",
     "310809"
    ],
    "spl_id": [
     "5842ecc2-874a-481b-8997-afa9d862dc5d"
    ],
    "spl_set_id": [
     "50a58159-9572-4445-9859-b392632597da"
    ],
    "package_ndc": [
     "65862-161-90",
     "65862-162-30",
     "65862-162-90",
     "65862-163-90"
    ],
    "nui": [
     "N0000175359",
     "N0000175419",
     "M0471776"
    ],
    "pharm_class_pe": [
     "Increased Diuresis [PE]"
    ],
    "pharm_class_epc": [
     "Thiazide Diuretic [EPC]"
    ],
    "pharm_class_cs": [
     "Thiazides [CS]"
    ],
    "unii": [
     "0J48LPH2TH",
     "33067B3N2M"
    ]
   },
   "update_date": "06/02/2026",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Tablet",
   "presentation": "Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 65862-161-90)",
   "company_name": "Aurobindo Pharma USA",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "01/19/2023",
   "package_ndc": "62135-668-90",
   "generic_name": "Quinapril/Hydrochlorothiazide Tablet",
   "contact_info": "845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA076374"
    ],
    "brand_name": [
     "QUINAPRIL AND HYDROCHLOROTHIAZIDE"
    ],
    "generic_name": [
     "QUINAPRIL AND HYDROCHLOROTHIAZIDE"
    ],
    "manufacturer_name": [
     "Chartwell RX, LLC"
    ],
    "product_ndc": [
     "62135-668",
     "62135-667",
     "62135-669"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "QUINAPRIL HYDROCHLORIDE",
     "HYDROCHLOROTHIAZIDE"
    ],
    "rxcui": [
     "310796",
     "310797",
     "310809"
    ],
    "spl_id": [
     "0c3f4504-d57e-aa79-e063-6294a90ad5b8"
    ],
    "spl_set_id": [
     "2eae533f-d0af-47e8-a1f2-94bc8cc89b5a"
    ],
    "package_ndc": [
     "62135-667-90",
     "62135-668-90",
     "62135-669-90"
    ],
    "nui": [
     "N0000175359",
     "N0000175419",
     "M0471776"
    ],
    "pharm_class_pe": [
     "Increased Diuresis [PE]"
    ],
    "pharm_class_epc": [
     "Thiazide Diuretic [EPC]"
    ],
    "pharm_class_cs": [
     "Thiazides [CS]"
    ],
    "unii": [
     "0J48LPH2TH",
     "33067B3N2M"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Tablet",
   "presentation": "Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 62135-668-90)",
   "company_name": "Chartwell Molecular Holdings LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "01/19/2023",
   "package_ndc": "62135-669-90",
   "generic_name": "Quinapril/Hydrochlorothiazide Tablet",
   "contact_info": "845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA076374"
    ],
    "brand_name": [
     "QUINAPRIL AND HYDROCHLOROTHIAZIDE"
    ],
    "generic_name": [
     "QUINAPRIL AND HYDROCHLOROTHIAZIDE"
    ],
    "manufacturer_name": [
     "Chartwell RX, LLC"
    ],
    "product_ndc": [
     "62135-669",
     "62135-667",
     "62135-668"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "QUINAPRIL HYDROCHLORIDE",
     "HYDROCHLOROTHIAZIDE"
    ],
    "rxcui": [
     "310796",
     "310797",
     "310809"
    ],
    "spl_id": [
     "0c3f4504-d57e-aa79-e063-6294a90ad5b8"
    ],
    "spl_set_id": [
     "2eae533f-d0af-47e8-a1f2-94bc8cc89b5a"
    ],
    "package_ndc": [
     "62135-667-90",
     "62135-668-90",
     "62135-669-90"
    ],
    "nui": [
     "N0000175359",
     "N0000175419",
     "M0471776"
    ],
    "pharm_class_pe": [
     "Increased Diuresis [PE]"
    ],
    "pharm_class_epc": [
     "Thiazide Diuretic [EPC]"
    ],
    "pharm_class_cs": [
     "Thiazides [CS]"
    ],
    "unii": [
     "0J48LPH2TH",
     "33067B3N2M"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Tablet",
   "presentation": "Quinapril/Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 62135-669-90)",
   "company_name": "Chartwell Molecular Holdings LLC",
   "status": "Current"
  }
 ]
}